BIOREM Inc.
BRM.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.53M | 2.29M | 2.00M | 2.23M | 3.82M |
| Total Depreciation and Amortization | 368.80K | 408.00K | 383.80K | 344.70K | 389.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 168.20K | 481.70K | 380.10K | 459.20K | 1.33M |
| Change in Net Operating Assets | -310.50K | 184.40K | 181.40K | -260.50K | -1.53M |
| Cash from Operations | 1.75M | 3.37M | 2.95M | 2.77M | 4.01M |
| Capital Expenditure | -246.80K | -247.00K | -69.70K | -275.70K | -183.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -246.80K | -247.00K | -69.70K | -275.70K | -183.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -666.90K | -724.50K | -707.40K | -729.00K | -697.00K |
| Issuance of Common Stock | 156.90K | 156.90K | 156.90K | 156.90K | 0.00 |
| Repurchase of Common Stock | -100.10K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -436.60K | -407.20K | -396.30K | -421.60K | -512.80K |
| Foreign Exchange rate Adjustments | -386.80K | -63.60K | 114.60K | 139.30K | 308.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 682.80K | 2.65M | 2.60M | 2.22M | 3.62M |